Governing lipitor and lipstick: Capacity, sequencing, and power in international pharmaceutical and cosmetics regulation

Review of International Political Economy

Volumn 17, Issue 4, 2010, Pages 665-695

  Bach, David ^a   Newman, Abraham L ^b  

^a IE BUSINESS SCHOOL   (Spain)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Cosmetics; Historical institutionalism; Pharmaceuticals; Regulatory capacity; Sequencing; Transgovernmental politics

Indexed keywords

EID: 77957793394     PISSN: 09692290     EISSN: 14664526     Source Type: Journal    
DOI: 10.1080/09692291003723706     Document Type: Review

References (63)

1. Abbott, K. and Snidal, D. (1988) 'Why States Act through Formal International Organizations', Journal of Conflict Resolution, 42: 3-32.
2. Abraham, J. (2004) 'Pharmaceuticals, the State, and the Global Harmonization Process', Australian Health Review, 28: 150-60.
3. Abraham, J. and Reed, T. (2001) 'Trading Risks for Markets: The International Harmonisation of Pharmaceuticals Regulation', Health, Risk and Society, 3: 113-28.
4. Aggarwal, V. (1985) Liberal Protectionism, Berkeley, CA: University of California Press.
5. Bach, D. and Newman, A. (2007) 'The European Regulatory State and Global Public Policy: Micro-Institutions and Macro-Influence', Journal of European Public Policy 16: 827-46.
6. Blaschke, J. (2005) 'Globalization of Cosmetic Regulation,' Food and Drug Law Journal, 60: 413-20.
7. Booth, P. (1997) 'Who Knows Where the Time Goes? FDA Implementation of Standards by the International Conference on Harmonisation', Food and Drug Law Journal, 52: 203.
8. B̈orzel, T. (1998) 'Organizing Babylon: on different conceptions of policy networks', Public Administration, 76: 253-73.
9. Braithwaite, J. and Drahos, P. (2000) Global Business Regulation, Cambridge: Cambridge University Press.
10. B̈uthe, T. (2002) 'Taking Temporality Seriously: Modeling History and the Use of Narratives as Evidence', American Political Science Review, 96: 481-93.
11. Carpenter, D. (2001) Forging of Bureaucratic Autonomy: reputations, networks, and policy innovation in executive agencies, Princeton,NJ: Princeton University Press.
12. Carvajal, D. (2007) 'Growing artificial skin to change how cosmetics firm test products', New York Times, November 16, 2007, http://www.nytimes.com/2007/11/16/business/worldbusiness/16iht-WBCELL.1.8363140.html?r=1&scp=95&sq=carvajal&st=nyt (accessed 11 August 2010).
13. Damro, C. (2006) 'Transatlantic Competition Policy: Domestic and International Sources of EU-US Cooperation', European Journal of International Relations, 12: 171-96.
14. Donnellan, L. (2007) 'Animal Testing in Cosmetics: Recent Developments in the European Union and the United States', Animal Law, 13: 251.
15. Drezner, D. W. (2005) 'Globalization, Coercion, and Competition: The Competing Pathways to Policy Convergence', Journal of European Public Policy, 12(8): 41-59.
16. Drezner, D. (2007) All Politics is Global: Explaining International Regulatory Regimes, Princeton, NJ: Princeton University Press, pp. 251-280.
17. Elbe, S. (2008) 'Our Epidemiological Footprint: The Circulation of Avian Flu, SARS, and HIV/AIDS in the World Economy', Review of International Political Economy, 15: 116-130.
18. Feick, J. (2002) 'Regulatory Europeanization, National Autonomy and Regulatory Effectiveness: Marketing Authorization of Pharmaceuticals', Max Planck Institut Discussion Paper, 2: 1-25.
19. Fox, E. (1997) 'Toward World Antitrust and Market Access', American Journal of International Law, 91: 1-25.
20. Frieden, J. and Martin, L. (2002) 'International Political Economy: Global and Domestic Interactions', in I. Katznelson and H. Milner (eds) Political Science: State of the Discipline, New York: Norton, pp. 118-146.
21. Gilardi, F. (2002) 'Policy Credibility and Delegation to Independent Regulatory Agencies: a comparative empirical analysis', Journal of European Public Policy, 9: 873-93.
22. Global Insight (2007) A Study of the European Cosmetics Industry, Milan: Prepared for the European Commission.
23. Health, I. (2004) IMS World Review. Norwalk, CT.
24. Henney, J. (2001) 'FDA & Globalization in the 21st Century', Biomedical Market Newsletter, Jan 31, 2001.
25. James, S. and Lake, D. (1989) 'The second face of hegemony: Britain's repeal of the Corn Laws and the AmericanWalker tariff of 1846', International Organization, 43: 1-29.
26. Kahler, M. and Lake, D. (2003) Governance in a Global Economy: A Political Authority in Transition, Princeton, NJ: Princeton University Press.
27. Kelly, D. and Bachorik, L. (2005) 'Promoting Public Health and Protecting Consumers in a Global Economy: An Overview of HHS/FDA's International Activities', Food and Drug Law Journal, 60: 339-46.
28. Keohane, R. (1984) After Hegemony, Princeton, NJ: Princeton University Press.
29. Kidd, D. (1996-97) 'The International Conference on Harmonization of Pharmaceutical Regulation, the European Medicines Evaluation Agency, and the FDA: Who's Zooming Who', Global Legal Studies Journal, 4: 182-206.
30. Koremenos, B., Lipson, C. and Snidal, D. (2001) 'The Rational Design of International Institutions', International Organization, 55: 761-99.
31. Kulynych, J. (1999) 'Will FDA Relinquish the 'Gold Standard' for New Drug Approval?', Food and Drug Law Journal, 54: 127-49.
32. Lee, P. and Herzstein, J. (1986) 'International Drug Regulation', Annual Review of Public Health, 7: 217-35.
33. Lee, J. John. (2005) 'What is Past is Prologue: The International Conference on Harmonization and Lessons Learned from European Drug Regulations Harmonization, University of Pennsylvania', Journal of International Economic Law, 26(1): 151-91.
34. Mahoney, J. (2000) 'Path Dependence in Historical Sociology', Theory and Society, 29: 507-48.
35. Majone, G. (1996) Regulating Europe, New York: Routledge.
36. Martin, L. and Simmons, B. (1998) 'Theories and Empirical Studies of International Institutions', International Organization, 52: 729-53.
37. Mattli, W. and B̈ uthe, T. (2003) 'Setting International Standards: Technological Rationality or Primacy of Power', World Politics, 56: 1-42.
38. Milner, H. (1997) Interests, Institutions, and Information, Princeton, NJ: Princeton University Press.
39. Molzon, J. (2005) 'The International Conference on Harmonization Common Technical Document - Global Submission Format?', Food and Drug Law Journal, 60: 447-51.
40. Newman, A. (2008a) 'Building Transnational Civil Liberties: Transgovernmental Entrepreneurs and the European Data Privacy Directive', International Organization 62: 103-30.
41. Newman, A. (2008b) Protectors of Privacy: Regulating Personal Data in the Global Economy, Ithaca, NY: Cornell University Press.
42. Oh, C. H. and Rugman, A. (2006) 'Regional Sales of Multinationals in the World Cosmetics Industry', European Management Journal, 24: 163-73.
43. Pierson, P. (2004) Politics in Time: History, Institutions, and Social Analysis, Princeton, NJ: Princeton University Press.
44. Posner, E. (2009) 'Making Rules for Global Finance: Transatlantic Regulatory Cooperation at the Turn of the Millennium', International Organization, 63: 665-99.
45. Putnam, R. (1988) 'Diplomacy and Domestic Politics: The logic of two-level games', International Organization, 42: 427-60.
46. Raustiala, K. (2002) 'The Architecture of International Cooperation: Transgovernmental Networks and the Future of International Law', Virginia Journal of International Law, 43: 1-92.
47. Richards, J. (1999) 'Toward a positive theory of international institutions: regulating international aviation markets', International Organization, 53: 1-37.
48. Risk and Policy Analysts. (2004) 'Comparative Study on Cosmetics Legislation in the EU and Other Principal Markets with Attention to so-called Borderline Products', Norfolk: Prepared for the European Commission.
49. Risse, T. (2000) 'Let's Argue!' Communicative Action in World Politics', International Organization, 54: 1-39.
50. Shambough, G. (1996) 'Dominance, Dependence, and Political Power: Tethering technology in the 1980s and today', International Studies Quarterly, 40: 559-88.
51. Shani, S. and Yahalom, Z. (2008) 'The Role of the Pharmaceutical Industry in Disseminating Pharmacovigilance Practice in Developing Countries', Food and Drug Law Journal, 63(3): 701-11.
52. Simmons, B. (2001) 'The International Politics of Harmonization: The Case of Capital Market Regulation', International Organization, 55: 589-620.
53. Singer, D.A. (2007) Regulating Capital: Setting Standards for the International Financial System, Ithaca, NY: Cornell University Press.
54. Slaughter, A.-M. (2004) A New World Order, Princeton, NJ: Princeton University Press.
55. Spar, D. (2001) Ruling the Waves, NewYork: Harcourt.
56. Streeck, W. and Thelen, K. (eds) (2005) Beyond continuity: institutional change in advanced political economies, Oxford: Oxford University Press.
57. Termini, R. and Tressler, L. (2008) 'American Beauty: An Analytical View of the Past and Current Effectiveness of Cosmetic Safety Regulations and Future Direction', Food and Drug Law Journal, 63(1): 257-74.
58. Thelen, K. (2004) How Institutions Evolve: The Political Economy of Skills in Germany, Britain, the United States, and Japan, Cambridge: Cambridge University Press.
59. Vogel, D. (1995) Trading Up: Consumer and Environmental Regulation in a Global Economy, Cambridge, MA: Harvard University Press.
60. Vogel, D. (1998) 'The Globalization of Pharmaceutical Regulation', Governance, 11: 1-22.
61. Vogel, S. (1996) Freer Markets More Rules: Regulatory Reform in Advanced Industrial Countries, Ithaca, NY: Cornell University Press.
62. Wiktorowicz, M. (2003) 'Emergent Patterns in the Regulation of Pharmaceuticals: Institutions and Interests in the United States, Canada, Britain, and France', Journal of Health Politics, Policy, and Law, 28: 615-58.
63. Zysman, J. (1994) 'How Institutions Create Historically Rooted Trajectories of Growth', Industrial and Corporate Change, 3: 243-83.